Operating Income Summary of Celltrion, Inc.

Celltrion, Inc.'s latest annual operating income in 2023 was 651.43 Billion KRW , up 0.65% from previous year.
Celltrion, Inc.'s latest quarterly operating income in 2024 Q2 was 72.48 Billion KRW , up 369.56% from previous quarter.
Celltrion, Inc. reported an annual operating income of 647.19 Billion KRW in 2022, down -14.49% from previous year.
Celltrion, Inc. reported an annual operating income of 756.85 Billion KRW in 2021, up 5.33% from previous year.
Celltrion, Inc. reported a quarterly operating income of 15.43 Billion KRW for 2024 Q1, down -16.09% from previous quarter.
Celltrion, Inc. reported a quarterly operating income of 651.43 Billion KRW for 2023 FY, up 0.65% from previous quarter.

Annual Operating Income Chart of Celltrion, Inc. (2023 - 2007)

Historical Annual Operating Income of Celltrion, Inc. (2023 - 2007)

Year	Operating Income	Operating Income Growth
2023	651.43 Billion KRW	0.65%
2022	647.19 Billion KRW	-14.49%
2021	756.85 Billion KRW	5.33%
2020	718.57 Billion KRW	88.34%
2019	381.53 Billion KRW	18.07%
2018	323.13 Billion KRW	-35.32%
2017	499.58 Billion KRW	100.08%
2016	249.69 Billion KRW	-3.58%
2015	258.95 Billion KRW	28.53%
2014	201.46 Billion KRW	101.78%
2013	99.84 Billion KRW	-48.92%
2012	195.44 Billion KRW	9.0%
2011	179.3 Billion KRW	68.18%
2010	106.61 Billion KRW	48.59%
2009	71.75 Billion KRW	133.18%
2008	30.77 Billion KRW	1765.14%
2007	1.64 Billion KRW	0.0%

Year	Operating Income	Operating Income Growth
2024 Q2	72.48 Billion KRW	369.56%
2024 Q1	15.43 Billion KRW	-16.09%
2023 FY	651.43 Billion KRW	0.65%
2023 Q4	18.39 Billion KRW	-93.13%
2023 Q1	182.43 Billion KRW	214.56%
2023 Q3	267.62 Billion KRW	46.25%
2023 Q2	182.99 Billion KRW	0.31%
2022 Q4	57.99 Billion KRW	-72.87%
2022 Q3	213.76 Billion KRW	7.44%
2022 Q2	198.96 Billion KRW	39.84%
2022 Q1	142.28 Billion KRW	-35.91%
2022 FY	647.19 Billion KRW	-14.49%
2021 Q3	163.97 Billion KRW	0.47%
2021 Q1	207.65 Billion KRW	21.28%
2021 Q2	163.2 Billion KRW	-21.4%
2021 FY	756.85 Billion KRW	5.33%
2021 Q4	222.01 Billion KRW	35.4%
2020 Q4	171.22 Billion KRW	-30.19%
2020 FY	718.57 Billion KRW	88.34%
2020 Q1	120.24 Billion KRW	2.19%
2020 Q3	245.27 Billion KRW	34.88%
2020 Q2	181.84 Billion KRW	51.23%
2019 Q1	77.35 Billion KRW	172.05%
2019 FY	381.53 Billion KRW	18.07%
2019 Q3	103.14 Billion KRW	23.74%
2019 Q4	117.66 Billion KRW	14.07%
2019 Q2	83.36 Billion KRW	7.76%
2018 Q3	73.62 Billion KRW	-31.97%
2018 Q4	28.43 Billion KRW	-61.38%
2018 FY	323.13 Billion KRW	-35.32%
2018 Q1	116.46 Billion KRW	-11.61%
2018 Q2	108.22 Billion KRW	-7.08%
2017 Q2	138.32 Billion KRW	54.74%
2017 FY	499.58 Billion KRW	100.08%
2017 Q4	131.75 Billion KRW	-5.96%
2017 Q3	140.1 Billion KRW	1.28%
2017 Q1	89.39 Billion KRW	24.84%
2016 Q4	71.6 Billion KRW	-3.24%
2016 Q3	74 Billion KRW	-4.02%
2016 Q1	26.98 Billion KRW	-57.71%
2016 FY	249.69 Billion KRW	-3.58%
2016 Q2	77.1 Billion KRW	185.74%
2015 Q1	40.91 Billion KRW	28.49%
2015 Q3	73.13 Billion KRW	-9.83%
2015 Q4	63.8 Billion KRW	-12.76%
2015 Q2	81.1 Billion KRW	98.25%
2015 FY	258.95 Billion KRW	28.53%
2014 Q2	97.95 Billion KRW	174.74%
2014 FY	201.46 Billion KRW	101.78%
2014 Q4	31.84 Billion KRW	-11.62%
2014 Q3	36.02 Billion KRW	-63.22%
2014 Q1	35.65 Billion KRW	268.93%
2013 Q3	41.79 Billion KRW	17.35%
2013 FY	99.84 Billion KRW	-48.92%
2013 Q4	-21.1 Billion KRW	-150.5%
2013 Q1	43.53 Billion KRW	-31.49%
2013 Q2	35.61 Billion KRW	-18.19%
2012 FY	195.44 Billion KRW	9.0%
2012 Q1	43.44 Billion KRW	0.0%
2012 Q3	44.41 Billion KRW	8.44%
2012 Q4	63.54 Billion KRW	43.09%
2012 Q2	40.95 Billion KRW	-5.72%
2011 Q3	47.5 Billion KRW	9.71%
2011 Q2	43.3 Billion KRW	10.22%
2011 Q1	39.28 Billion KRW	77.6%
2011 FY	179.3 Billion KRW	68.18%
2011 Q4	- KRW	-100.0%
2010 Q2	30.01 Billion KRW	34.25%
2010 Q1	22.36 Billion KRW	31.41%
2010 Q3	32.11 Billion KRW	6.99%
2010 Q4	22.12 Billion KRW	-31.12%
2010 FY	106.61 Billion KRW	48.59%
2009 Q4	17.01 Billion KRW	6.73%
2009 FY	71.75 Billion KRW	133.18%
2009 Q3	15.94 Billion KRW	-23.26%
2009 Q2	20.77 Billion KRW	15.31%
2009 Q1	18.01 Billion KRW	327.9%
2008 Q1	483.67 Million KRW	0.0%
2008 Q3	18.87 Billion KRW	3992.41%
2008 Q4	4.21 Billion KRW	-77.7%
2008 FY	30.77 Billion KRW	1765.14%
2008 Q2	-485 Million KRW	-200.28%
2007 Q4	- KRW	-100.0%
2007 Q2	525.82 Million KRW	-34.43%
2007 Q1	801.88 Million KRW	0.0%
2007 FY	1.64 Billion KRW	0.0%
2007 Q3	884.52 Million KRW	68.22%

Peer Operating Income Comparison of Celltrion, Inc.

Name	Operating Income	Operating Income Difference
ORIENT BIO Inc.	1.45 Billion KRW	-44739.597%
Green Cross Holdings Corporation	-16.43 Billion KRW	4062.997%
Green Cross Holdings Corporation	34.43 Billion KRW	-1791.715%
Pharmicell Co., Ltd.	950.99 Million KRW	-68400.167%
Green Cross Corporation	34.43 Billion KRW	-1791.715%
GeneOne Life Science, Inc.	-48.36 Billion KRW	1446.828%
Samsung Biologics Co.,Ltd.	1155.98 Billion KRW	43.647%
SK bioscience Co.,Ltd.	-4.73 Billion KRW	13869.517%
SK Biopharmaceuticals Co., Ltd.	-37.52 Billion KRW	1836.13%
Prestige BioPharma Limited	-62.78 Billion KRW	1137.598%

Global Stocks Search

Celltrion, Inc. (068270.KS)

Operating Income Summary of Celltrion, Inc.

Annual Operating Income Chart of Celltrion, Inc. (2023 - 2007)

Historical Annual Operating Income of Celltrion, Inc. (2023 - 2007)

Peer Operating Income Comparison of Celltrion, Inc.